 |
Previous Article | Next Article 
The Journal of Neuroscience, June 15, 1999, 19(12):4867-4880
Expression of Human Apolipoprotein E3 or E4 in the Brains of
Apoe / Mice: Isoform-Specific Effects on
Neurodegeneration
Manuel
Buttini1, 4,
Matthias
Orth1, 2,
Stefano
Bellosta1, 2,
Hassibullah
Akeefe1,
Robert E.
Pitas1, 2, 5,
Tony
Wyss-Coray1, 4,
Lennart
Mucke1, 4, and
Robert W.
Mahley1, 2, 3, 5
1 Gladstone Institute of Neurological Disease,
2 Cardiovascular Research Institute, and Departments of
3 Medicine, 4 Neurology, and
5 Pathology, University of California, San Francisco,
California 94141-9100
Apolipoprotein (apo) E isoforms are key determinants of
susceptibility to Alzheimer's disease. The apoE4 isoform is the major known genetic risk factor for this disease and is also associated with
poor outcome after acute head trauma or stroke. To test the hypothesis
that apoE3, but not apoE4, protects against age-related and
excitotoxin-induced neurodegeneration, we analyzed apoE knockout (Apoe / ) mice expressing similar
levels of human apoE3 or apoE4 in the brain under control of the
neuron-specific enolase promoter. Neuronal apoE expression was
widespread in the brains of these mice. Kainic acid-challenged
wild-type or Apoe / mice had a
significant loss of synaptophysin-positive presynaptic terminals and
microtubule-associated protein 2-positive neuronal dendrites in the
neocortex and hippocampus, and a disruption of neurofilament-positive
axons in the hippocampus. Expression of apoE3, but not of apoE4,
protected against this excitotoxin-induced neuronal damage. ApoE3, but
not apoE4, also protected against the age-dependent neurodegeneration
seen in Apoe / mice. These
differences in the effects of apoE isoforms on neuronal integrity may
relate to the increased risk of Alzheimer's disease and to the poor
outcome after head trauma and stroke associated with apoE4 in humans.
Key words:
apolipoprotein E; Alzheimer's disease; apoE transgenic
mice; excitotoxicity; apoE knockout mice; neurodegeneration
Copyright © 1999 Society for Neuroscience 0270-6474/99/19124867-14$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
Q. Xu, D. Walker, A. Bernardo, J. Brodbeck, M. E. Balestra, and Y. Huang
Intron-3 Retention/Splicing Controls Neuronal Expression of Apolipoprotein E in the CNS
J. Neurosci.,
February 6, 2008;
28(6):
1452 - 1459.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Brodbeck, M. E. Balestra, A. M. Saunders, A. D. Roses, R. W. Mahley, and Y. Huang
Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons
PNAS,
January 29, 2008;
105(4):
1343 - 1346.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. McConlogue, M. Buttini, J. P. Anderson, E. F. Brigham, K. S. Chen, S. B. Freedman, D. Games, K. Johnson-Wood, M. Lee, M. Zeller, et al.
Partial Reduction of BACE1 Has Dramatic Effects on Alzheimer Plaque and Synaptic Pathology in APP Transgenic Mice
J. Biol. Chem.,
September 7, 2007;
282(36):
26326 - 26334.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Medeiros, R. D. S. Prediger, G. F. Passos, P. Pandolfo, F. S. Duarte, J. L. Franco, A. L. Dafre, G. Di Giunta, C. P. Figueiredo, R. N. Takahashi, et al.
Connecting TNF-{alpha} Signaling Pathways to iNOS Expression in a Mouse Model of Alzheimer's Disease: Relevance for the Behavioral and Synaptic Deficits Induced by Amyloid {beta} Protein
J. Neurosci.,
May 16, 2007;
27(20):
5394 - 5404.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Luo, A. H. Lin, E. Masliah, and T. Wyss-Coray
Bioluminescence imaging of Smad signaling in living mice shows correlation with excitotoxic neurodegeneration
PNAS,
November 28, 2006;
103(48):
18326 - 18331.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Xu, A. Bernardo, D. Walker, T. Kanegawa, R. W. Mahley, and Y. Huang
Profile and Regulation of Apolipoprotein E (ApoE) Expression in the CNS in Mice with Targeting of Green Fluorescent Protein Gene to the ApoE Locus.
J. Neurosci.,
May 10, 2006;
26(19):
4985 - 4994.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Esposito, J. Raber, L. Kekonius, F. Yan, G.-Q. Yu, N. Bien-Ly, J. Puolivali, K. Scearce-Levie, E. Masliah, and L. Mucke
Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice.
J. Neurosci.,
May 10, 2006;
26(19):
5167 - 5179.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Mahley, K. H. Weisgraber, and Y. Huang
Inaugural Article: Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease
PNAS,
April 11, 2006;
103(15):
5644 - 5651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C Smith, D I Graham, L S Murray, J Stewart, and J A R Nicoll
Association of APOE e4 and cerebrovascular pathology in traumatic brain injury.
J. Neurol. Neurosurg. Psychiatry,
March 1, 2006;
77(3):
363 - 366.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-S. Ji, K. Mullendorff, I. H. Cheng, R. D. Miranda, Y. Huang, and R. W. Mahley
Reactivity of Apolipoprotein E4 and Amyloid beta Peptide: LYSOSOMAL STABILITY AND NEURODEGENERATION
J. Biol. Chem.,
February 3, 2006;
281(5):
2683 - 2692.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Huang
Apolipoprotein E and Alzheimer disease
Neurology,
January 24, 2006;
66(1_suppl_1):
S79 - S85.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chang, T. r. Ma, R. D. Miranda, M. E. Balestra, R. W. Mahley, and Y. Huang
Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity
PNAS,
December 20, 2005;
102(51):
18694 - 18699.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Ramaswamy, Q. Xu, Y. Huang, and K. H. Weisgraber
Effect of Domain Interaction on Apolipoprotein E Levels in Mouse Brain
J. Neurosci.,
November 16, 2005;
25(46):
10658 - 10663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Buttini, E. Masliah, R. Barbour, H. Grajeda, R. Motter, K. Johnson-Wood, K. Khan, P. Seubert, S. Freedman, D. Schenk, et al.
{beta}-Amyloid Immunotherapy Prevents Synaptic Degeneration in a Mouse Model of Alzheimer's Disease
J. Neurosci.,
October 5, 2005;
25(40):
9096 - 9101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N Scarmeas, C G Habeck, J Hilton, K E Anderson, J Flynn, A Park, and Y Stern
APOE related alterations in cerebral activation even at college age
J. Neurol. Neurosurg. Psychiatry,
October 1, 2005;
76(10):
1440 - 1444.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Lanterna, M. Rigoldi, G. Tredici, F. Biroli, C. Cesana, S. M. Gaini, and L. Dalpra
APOE influences vasospasm and cognition of noncomatose patients with subarachnoid hemorrhage
Neurology,
April 12, 2005;
64(7):
1238 - 1244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Scarmeas, C. Habeck, K. E. Anderson, J. Hilton, D. P. Devanand, G. H. Pelton, M. H. Tabert, J. Flynn, A. Park, A. Ciappa, et al.
Altered PET Functional Brain Responses in Cognitively Intact Elderly Persons at Risk for Alzheimer Disease (Carriers of the {epsilon}4 Allele)
Am J Geriatr Psychiatry,
December 1, 2004;
12(6):
596 - 605.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. M. Harris, W. J. Brecht, Q. Xu, R. W. Mahley, and Y. Huang
Increased tau Phosphorylation in Apolipoprotein E4 Transgenic Mice Is Associated with Activation of Extracellular Signal-regulated Kinase: MODULATION BY ZINC
J. Biol. Chem.,
October 22, 2004;
279(43):
44795 - 44801.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Xu, W. J. Brecht, K. H. Weisgraber, R. W. Mahley, and Y. Huang
Apolipoprotein E4 Domain Interaction Occurs in Living Neuronal Cells as Determined by Fluorescence Resonance Energy Transfer
J. Biol. Chem.,
June 11, 2004;
279(24):
25511 - 25516.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chin, J. J. Palop, G.-Q. Yu, N. Kojima, E. Masliah, and L. Mucke
Fyn Kinase Modulates Synaptotoxicity, But Not Aberrant Sprouting, in Human Amyloid Precursor Protein Transgenic Mice
J. Neurosci.,
May 12, 2004;
24(19):
4692 - 4697.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Raber
Androgens, ApoE, and Alzheimer's Disease
Sci. Aging Knowl. Environ.,
March 17, 2004;
2004(11):
re2 - re2.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. J. Brecht, F. M. Harris, S. Chang, I. Tesseur, G.-Q. Yu, Q. Xu, J. Dee Fish, T. Wyss-Coray, M. Buttini, L. Mucke, et al.
Neuron-Specific Apolipoprotein E4 Proteolysis Is Associated with Increased Tau Phosphorylation in Brains of Transgenic Mice
J. Neurosci.,
March 10, 2004;
24(10):
2527 - 2534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. M. Harris, I. Tesseur, W. J. Brecht, Q. Xu, K. Mullendorff, S. Chang, T. Wyss-Coray, R. W. Mahley, and Y. Huang
Astroglial Regulation of Apolipoprotein E Expression in Neuronal Cells: IMPLICATIONS FOR ALZHEIMER'S DISEASE
J. Biol. Chem.,
January 30, 2004;
279(5):
3862 - 3868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. M. Harris, W. J. Brecht, Q. Xu, I. Tesseur, L. Kekonius, T. Wyss-Coray, J. D. Fish, E. Masliah, P. C. Hopkins, K. Scearce-Levie, et al.
Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice
PNAS,
September 16, 2003;
100(19):
10966 - 10971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N Nathoo, R Chetty, J R van Dellen, and G H Barnett
Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E
Mol. Pathol.,
June 1, 2003;
56(3):
132 - 136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Diaz-Arrastia, Y. Gong, S. Fair, K. D. Scott, M. C. Garcia, M. C. Carlile, M. A. Agostini, and P. C. Van Ness
Increased Risk of Late Posttraumatic Seizures Associated With Inheritance of APOE{epsilon}4 Allele
Arch Neurol,
June 1, 2003;
60(6):
818 - 822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Han, H. Cheng, J. D. Fryer, A. M. Fagan, and D. M. Holtzman
Novel Role for Apolipoprotein E in the Central Nervous System. MODULATION OF SULFATIDE CONTENT
J. Biol. Chem.,
February 28, 2003;
278(10):
8043 - 8051.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Mayeux
Apolipoprotein E, Alzheimer Disease, and African Americans
Arch Neurol,
February 1, 2003;
60(2):
161 - 163.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Enzinger, S. Ropele, S. Strasser-Fuchs, P. Kapeller, H. Schmidt, B. Poltrum, R. Schmidt, H.-P. Hartung, and F. Fazekas
Lower Levels of N-Acetylaspartate in Multiple Sclerosis Patients With the Apolipoprotein E {epsilon}4 Allele
Arch Neurol,
January 1, 2003;
60(1):
65 - 70.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Buttini, G.-Q. Yu, K. Shockley, Y. Huang, B. Jones, E. Masliah, M. Mallory, T. Yeo, F. M. Longo, and L. Mucke
Modulation of Alzheimer-Like Synaptic and Cholinergic Deficits in Transgenic Mice by Human Apolipoprotein E Depends on Isoform , Aging, and Overexpression of Amyloid beta Peptides But Not on Plaque Formation
J. Neurosci.,
December 15, 2002;
22(24):
10539 - 10548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Hartman, H. Laurer, L. Longhi, K. R. Bales, S. M. Paul, T. K. McIntosh, and D. M. Holtzman
Apolipoprotein E4 Influences Amyloid Deposition But Not Cell Loss after Traumatic Brain Injury in a Mouse Model of Alzheimer's Disease
J. Neurosci.,
December 1, 2002;
22(23):
10083 - 10087.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Raber, G. Bongers, A. LeFevour, M. Buttini, and L. Mucke
Androgens Protect against Apolipoprotein E4-Induced Cognitive Deficits
J. Neurosci.,
June 15, 2002;
22(12):
5204 - 5209.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Bissel, G. Wang, M. Ghosh, T. A. Reinhart, S. Capuano III, K. Stefano Cole, M. Murphey-Corb, M. Piatak Jr., J. D. Lifson, and C. A. Wiley
Macrophages Relate Presynaptic and Postsynaptic Damage in Simian Immunodeficiency Virus Encephalitis
Am. J. Pathol.,
March 1, 2002;
160(3):
927 - 941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Peila, L.R. White, H. Petrovich, K. Masaki, G.W. Ross, R.J. Havlik, L.J. Launer, and J. Poirier
Joint Effect of the APOE Gene and Midlife Systolic Blood Pressure on Late-Life Cognitive Impairment: The Honolulu-Asia Aging Study Editorial Comment: The Honolulu-Asia Aging Study
Stroke,
December 1, 2001;
32(12):
2882 - 2889.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chapman, A. D. Korczyn, D. M. Karussis, and D. M. Michaelson
The effects of APOE genotype on age at onset and progression of neurodegenerative diseases
Neurology,
October 23, 2001;
57(8):
1482 - 1485.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Lesuisse, G. Xu, J. Anderson, M. Wong, J. Jankowsky, G. Holtz, V. Gonzalez, P. C. Y. Wong, D. L. Price, F. Tang, et al.
Hyper-expression of human apolipoprotein E4 in astroglia and neurons does not enhance amyloid deposition in transgenic mice
Hum. Mol. Genet.,
October 1, 2001;
10(22):
2525 - 2537.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Raffai, L.-M. Dong, R. V. Farese Jr., and K. H. Weisgraber
Introduction of human apolipoprotein E4 ""domain interaction"" into mouse apolipoprotein E
PNAS,
September 5, 2001;
(2001)
201279298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Huang, X. Q. Liu, T. Wyss-Coray, W. J. Brecht, D. A. Sanan, and R. W. Mahley
Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons
PNAS,
July 5, 2001;
(2001)
151254698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. R. Peskind, C. W. Wilkinson, E. C. Petrie, G. D. Schellenberg, and M. A. Raskind
Increased CSF cortisol in AD is a function of APOE genotype
Neurology,
April 24, 2001;
56(8):
1094 - 1098.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Grehan, E. Tse, and J. M. Taylor
Two Distal Downstream Enhancers Direct Expression of the Human Apolipoprotein E Gene to Astrocytes in the Brain
J. Neurosci.,
February 1, 2001;
21(3):
812 - 822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Mucke, G.-Q. Yu, L. McConlogue, E. M. Rockenstein, C. R. Abraham, and E. Masliah
Astroglial Expression of Human {{alpha}}1-Antichymotrypsin Enhances Alzheimer-like Pathology in Amyloid Protein Precursor Transgenic Mice
Am. J. Pathol.,
December 1, 2000;
157(6):
2003 - 2010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hashimoto, H. Jiang, T. Niikura, Y. Ito, A. Hagiwara, K. Umezawa, Y. Abe, Y. Murayama, and I. Nishimoto
Neuronal Apoptosis by Apolipoprotein E4 through Low-Density Lipoprotein Receptor-Related Protein and Heterotrimeric GTPases
J. Neurosci.,
November 15, 2000;
20(22):
8401 - 8409.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Mucke, E. Masliah, G.-Q. Yu, M. Mallory, E. M. Rockenstein, G. Tatsuno, K. Hu, D. Kholodenko, K. Johnson-Wood, and L. McConlogue
High-Level Neuronal Expression of Abeta 1-42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation
J. Neurosci.,
June 1, 2000;
20(11):
4050 - 4058.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Raber, S. F. Akana, S. Bhatnagar, M. F. Dallman, D. Wong, and L. Mucke
Hypothalamic-Pituitary-Adrenal Dysfunction in Apoe-/- Mice: Possible Role in Behavioral and Metabolic Alterations
J. Neurosci.,
March 1, 2000;
20(5):
2064 - 2071.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Huang, M. Buttini, T. Wyss-Coray, L. McConlogue, T. Kodama, R. E. Pitas, and L. Mucke
Elimination of the Class A Scavenger Receptor Does Not Affect Amyloid Plaque Formation or Neurodegeneration in Transgenic Mice Expressing Human Amyloid Protein Precursors
Am. J. Pathol.,
November 1, 1999;
155(5):
1741 - 1747.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Salero, R. Perez-Sen, J. Aruga, C. Gimenez, and F. Zafra
Transcription Factors Zic1 and Zic2 Bind and Transactivate the Apolipoprotein E Gene Promoter
J. Biol. Chem.,
January 12, 2001;
276(3):
1881 - 1888.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Huang, X. Q. Liu, T. Wyss-Coray, W. J. Brecht, D. A. Sanan, and R. W. Mahley
Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons
PNAS,
July 17, 2001;
98(15):
8838 - 8843.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Raffai, L.-M. Dong, R. V. Farese Jr., and K. H. Weisgraber
Introduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein E
PNAS,
September 25, 2001;
98(20):
11587 - 11591.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|